Drugs Affecting Homocysteine Metabolism: Impact on Cardiovascular Risk

Author： Desouza C.   Keebler M.   McNamara D.B.   Fonseca V.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.62, Iss.4, 2002-04, pp. : 605-616

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Homocysteine: A Risk Factor in Patietns with Cardiovascular Disorders in Pakistan

By  

Current Bioactive Compounds, Vol. 11, Iss. 4, 2015-12 ,pp. : 210-214

Bentham Science Publishers

Access to resources Recommend Favorite

Folate and Homocysteine Metabolism: Therapeutic Targets in Cardiovascular and Neurodegenerative Disorders

By  

Current Medicinal Chemistry, Vol. 10, Iss. 19, 2003-10 ,pp. : 1923-1929

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease

By Sunder-Plassmann G.   Winkelmayer W.C.   Födinger M.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2637-2652

Informa Healthcare

Access to resources Recommend Favorite

VDAC-Targeted Drugs Affecting Cytoprotection and Mitochondrial Physiology in Cerebrovascular and Cardiovascular Diseases

By  

Current Medicinal Chemistry, Vol. 24, Iss. 40, 2018-01 ,pp. : 4419-4434

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Mechanisms of COX-2 Selective Inhibitors Affecting Cardiovascular Risk

By Smith Howard S.  

Journal of Cancer Pain & Symptom Palliation, Vol. 2, Iss. 3, 2008-01 ,pp. : 5-18

Haworth Press

Access to resources Recommend Favorite